American Society of Clinical Oncology

SHERPA: White

People

  1. Motzer
    Motzer
  2. Scher
    Scher
  3. O'Reilly
    O'Reilly
  4. Saltz
    Saltz
  5. Kris
    Kris
  6. Hudis
    Hudis
  7. Morris
    Morris
  8. Bajorin
    Bajorin
  9. Rosenberg
    Rosenberg
  10. Robson
    Robson

Groups

  1. Department of Medicine (6319)
  2. Solid Tumor Oncology Division (5467)
  3. Survivorship Research (1986)
  4. Genitourinary Oncology Service (1750)
  5. Surgery (1629)
  6. Epidemiology and Biostatistics (1469)
  7. GSK Faculty (1371)
  8. Population Sciences Research Program (1371)
  9. Gastrointestinal Oncology Service (1336)
  10. Hematologic Malignancies, Division of (1262)
Search Within
Formats
  1. Meeting Abstract (6250)
  2. Journal Article (2557)
  3. Editorial (74)
  4. Review (69)
  5. Guidelines (56)
  6. Correspondence (46)
  7. Miscellaneous (4)
  8. Conference Paper (3)
Groups
  1. Department of Medicine (6319)
  2. Solid Tumor Oncology Division (5467)
  3. Survivorship Research (1986)
  4. Genitourinary Oncology Service (1750)
  5. Surgery (1629)
  6. Epidemiology and Biostatistics (1469)

More Groups

People
  1. Robert Motzer (447)
  2. Howard Scher (334)
  3. Eileen O'Reilly (300)
  4. Leonard Saltz (282)
  5. Dean Bajorin (278)
  6. Mark Kris (252)

More People

Years
  1. 2025 (147)
  2. 2024 (566)
  3. 2023 (586)
  4. 2022 (556)
  5. 2021 (504)
  6. 2020 (539)

More Years

Publications
  1. Journal of Clinical Oncology (8576)
  2. JCO Precision Oncology (163)
  3. Journal of Oncology Practice (124)
  4. American Society of Clinical Oncology Educational Book (112)
  5. JCO Clinical Cancer Informatics (53)
  6. JCO Oncology Practice (18)

More Publications

Results (9059)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Outcomes after radiation for oligoprogressive disease sites in patients with EGFR-mutant lung cancer treated with osimertinib
    Journal Article

    Chen, M. F.; Jeng, M. Y.; Ma, J.; Agrawal, P.; Dunne, E.; Boe, L. A.; Kris, M. G.; Huang, J.; Veeraraghavan, H.; Gomez, D.; more...
    JCO Precision Oncology (2025)

    Fulltext@MSK | Save
  • Implementation of Recovery Tracker: A postdischarge electronic remote symptom-monitoring survey tool after major urologic oncology surgeries
    Journal Article

    Matulewicz, R. S.; Baky, F.; Gold, S.; Jayalath, V. H.; Yu, R.; Liso, N.; Tin, A. L.; Assel, M.; Vickers, A. J.; Hannon, M.; more...
    JCO Clinical Cancer Informatics (2025)

    Fulltext@MSK | Save
  • Impact of clonal hematopoiesis on solid tumor progression following radiation therapy
    Journal Article

    Tao, J. J.; Setton, J.; Vela, P. S.; Safonov, A. M.; Comen, E. A.; Braunstein, L. Z.; Reis-Filho, J. S.; Riaz, N.; Powell, S. N.; Levine, R. L.; more...
    JCO Precision Oncology (2025)

    Fulltext@MSK | Save
  • Patient-reported outcomes program at scale at a cancer center
    Journal Article

    Polubriaginof, F. C. G.; Lipitz-Snyderman, A.; Chimonas, S.; Kuperman, G. J.; Stetson, P. D.
    JCO Clinical Cancer Informatics (2025)

    Fulltext@MSK | Save
  • Cancer care in Jordan: Multidisciplinary solutions needed for complex disparities
    Editorial

    Aljassabi, A.; Zieneldien, T.; Kim, J.; Hammoudeh, L.; Sharkas, G.; Willmann, J.; Feliciano, E. J. G.; Dee, E. C.
    JCO Global Oncology (2025)

    Fulltext@MSK | Save
  • Larotrectinib compared with real-world non-tropomyosin receptor kinase inhibitor therapies in patients with tropomyosin receptor kinase fusion cancer
    Journal Article

    Brose, M. S.; Westphalen, C. B.; Pan, X.; Bernard-Gauthier, V.; Kurtinecz, M.; Guo, H.; Aris, V.; Brett, N. R.; Majdi, A.; Subbiah, V.; more...
    JCO Precision Oncology (2025)

    Fulltext@MSK | Save
  • A multicenter, open-label phase 1/2 study of TYRA-300 in advanced urothelial carcinoma and other solid tumors with activating FGFR3 alterations (SURF301)
    Meeting Abstract

    Hansen, A. R.; Zhang, A. Y.; Boni, V.; Mantia, C.; Yu, E. Y.; Weickhardt, A. J.; Robert, M.; Gupta, S.; Morales-Barrera, R.; Hoimes, C. J.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • P3BEP (ANZUP 1302): An international randomized phase 3 trial of accelerated versus standard BEP chemotherapy for individuals aged 11-50 years with intermediate and poor-risk metastatic germ cell tumours (GCTs)
    Meeting Abstract

    Mak, B.; Tran, B.; Thomas, H.; Pashankar, F. D.; Hansen, A. R.; Feldman, D. R.; Huddart, R. A.; Wheater, M.; Dunwoodie, E.; Mazhar, D.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • NEXUS-01, a phase 1 study of LY4052031, an antibody-drug conjugate targeting Nectin-4 in participants with advanced or metastatic urothelial carcinoma or other solid tumors
    Meeting Abstract

    Gao, X.; Patnaik, A.; Lakhani, N. J.; Call, J. A.; Galsky, M. D.; Garmezy, B.; Wei, A. Z.; Carter, L.; Powles, T.; Siefker-Radtke, A. O.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • INTerpath-004: A phase 2, randomized, double-blind study of adjuvant pembrolizumab (pembro) with V940 (mRNA-4157) or placebo for renal cell carcinoma (RCC)
    Meeting Abstract

    Motzer, R. J.; Braun, D. A.; Powles, T.; Gurney, H.; Fong, L.; George, D. J.; Haas, N. B.; McDermott, D. F.; Shuch, B. M.; Meehan, R.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save